📰 Accelerate Diagnostics News
Page 8 - Accelerate Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accelerate Diagnostics. Real-time updates on events, politics, business and more.
March 8, 2023
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the...
January 19, 2023
/PRNewswire/ -- According to Ariztons latest research report, the in-vitro diagnostics market will grow at a CAGR of 3.3% from 2022-2028. In recent years, IVD...
January 19, 2023
With More than USD 3 trillion Investment Opportunities Across Healthcare Services in North America Alone, the In-Vitro Diagnostics Market is Witnessing Huge Growth in North America. CHICAGO
January 5, 2023
/PRNewswire/ -- In Vitro Diagnostics Market is projected to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6% according to a...
January 5, 2023
CHICAGO, Jan. 5, 2023 /PRNewswire/ -- In Vitro Diagnostics Market is projected to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6% according to a new report
December 19, 2022
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that the Company has submitted a 510(k) application to the FDA for Gram-negative...
November 17, 2022
NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...
November 14, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. ("Accelerate" or the "Company") (NASDAQ: AXDX)....
November 14, 2022
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter for the period ended September 30, 2022....
November 4, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Accelerate Diagnostics, Inc. ("Accelerate" or the "Company") (NASDAQ: AXDX)....